DiaMedica Therapeutics Income Statement (2018-2026) | DMAC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)	2.16M	2.33M	1.87M	1.97M	1.96M	1.64M	2.27M	3.62M	2.54M	3.27M	3.68M	3.68M	3.93M	4.98M	6.47M	5.66M	5.82M	6.44M	6.70M	7.99M
Selling, General & Administrative (Quarter)	1.21M	1.08M	1.38M	1.56M	1.41M	1.49M	1.70M	1.90M	2.20M	1.89M	2.17M	2.06M	1.71M	1.90M	1.95M	2.49M	2.19M	2.60M	2.51M	2.50M
Operating Expenses (Quarter)	3.37M	3.42M	3.25M	3.54M	3.36M	3.13M	3.97M	5.52M	4.74M	5.16M	5.85M	5.74M	5.64M	6.88M	8.42M	8.14M	8.01M	9.03M	9.21M	10.48M
Operating Income (Quarter)	-3.37M	-3.42M	-3.25M	-3.54M	-3.36M	-3.13M	-3.97M	-5.52M	-4.74M	-5.16M	-5.85M	-5.74M	-5.64M	-6.88M	14.60M	-8.14M	-8.01M	-9.03M	-9.21M	-10.48M
EBIT (Quarter)	-3.37M	-3.42M	-3.25M	-3.54M	-3.36M	-3.13M	-3.97M	-5.52M	-4.74M	-5.16M	-5.85M	-5.74M	-5.64M	-6.88M	14.60M	-8.14M	-8.01M	-9.03M	-9.21M	-10.48M
Non-operating items
Interest & Investment Income (Quarter)												0.62M	0.52M	0.62M	0.54M	0.44M	0.31M	0.44M	0.47M	0.47M
Other Non Operating Income (Quarter)	0.10M	-0.03M	0.01M	0.04M	0.01M	0.08M	0.23M	0.26M	0.27M	0.69M	0.71M	0.60M	0.00M	-0.00M	2.29M	0.44M	0.00M	-0.02M	1.68M	0.45M
Non Operating Income (Quarter)	0.10M	-0.03M	0.01M	0.04M	0.01M	0.08M	0.23M	0.26M	0.27M	0.69M	0.71M	0.60M	0.53M	-0.00M	0.53M	0.44M	0.31M	-0.02M	1.68M	0.45M
Net income details
EBT (Quarter)	-3.27M	-3.44M	-3.24M	-3.50M	-3.35M	-3.05M	-3.74M	-5.26M	-4.47M	-4.46M	-5.14M	-5.14M	-5.11M	-6.27M	-7.93M	-7.70M	-7.69M	-8.61M	-9.11M	-10.04M
Tax Provisions (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Profit After Tax (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.90M	-7.71M	-7.70M	-8.62M	-8.77M	-10.00M
Income from Continuing Operations (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.94M	-7.71M	-7.70M	-8.62M	-9.12M	-10.04M
Consolidated Net Income (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.94M	-7.71M	-7.70M	-8.62M	-9.12M	-10.04M
Income towards Parent Company (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.94M	-7.71M	-7.70M	-8.62M	-9.12M	-10.04M
Net Income towards Common Stockholders (Quarter)	-3.27M	-3.45M	-3.25M	-3.51M	-3.36M	-3.06M	-3.75M	-5.27M	-4.48M	-4.47M	-5.16M	-5.15M	-5.12M	-6.27M	-7.94M	-7.71M	-7.70M	-8.62M	-9.12M	-10.04M
Additional items
EPS (Basic) (Quarter)	-0.17	-0.18	-0.10	-0.13	-0.13	-0.12	-0.14	-0.20	-0.16	-0.12	-0.14	-0.14	-0.13	-0.15	-0.18	-0.18	-0.18	-0.17	-0.17	-0.19
Shares Outstanding (Weighted Average) (Quarter)	18.78M	19.04M	20.77M	26.44M	26.44M	26.44M	26.44M	26.45M	27.31M	30.75M	32.57M	37.96M	38.07M	42.75M	40.40M	42.84M	42.90M	45.17M	46.98M	53.79M
EBITDA (Quarter)	-3.27M	-3.45M	-3.29M	-3.56M	-3.42M	-3.05M	-3.66M	-5.23M	-4.51M	-4.54M	-5.03M	-5.20M	-5.13M	-6.14M	-7.96M	-7.72M	-7.72M	-8.56M	-8.74M	-10.12M
Interest Expenses (Quarter)			19.39M				22.74M				28.04M	0.02M				0.00M				0.02M
Tax Rate (Quarter)	-0.21%	-0.20%	-0.22%	-0.20%	-0.21%	-0.23%	-0.19%	-0.13%	-0.16%	-0.16%	-0.43%	-0.14%	-0.14%	-0.11%	-0.11%	-0.08%	-0.08%	-0.07%	-0.11%	-0.07%

Research Tools

Developers

DiaMedica Therapeutics Income Statement (2018-2026) | DMAC

Research Tools

Developers

DiaMedica Therapeutics Income Statement (2018-2026) | DMAC

Create an account

Sign In

Reset Password